B. E. Smink

864 total citations
16 papers, 671 citations indexed

About

B. E. Smink is a scholar working on Toxicology, Pharmacology and Safety, Risk, Reliability and Quality. According to data from OpenAlex, B. E. Smink has authored 16 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Toxicology, 6 papers in Pharmacology and 4 papers in Safety, Risk, Reliability and Quality. Recurrent topics in B. E. Smink's work include Forensic Toxicology and Drug Analysis (11 papers), Cannabis and Cannabinoid Research (6 papers) and Traffic and Road Safety (4 papers). B. E. Smink is often cited by papers focused on Forensic Toxicology and Drug Analysis (11 papers), Cannabis and Cannabinoid Research (6 papers) and Traffic and Road Safety (4 papers). B. E. Smink collaborates with scholars based in Netherlands, Belgium and Finland. B. E. Smink's co-authors include Klaas J. Lusthof, Toine C. G. Egberts, Donald R. A. Uges, J.J. de Gier, Johan J. de Gier, D. R. A. Uges, Miranda Verschraagen, Tim Leufkens, Annemiek Vermeeren and Peter van Ruitenbeek and has published in prestigious journals such as Psychopharmacology, Accident Analysis & Prevention and Annals of Emergency Medicine.

In The Last Decade

B. E. Smink

15 papers receiving 627 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. E. Smink Netherlands 13 330 156 108 108 88 16 671
J.J. de Gier Netherlands 16 293 0.9× 133 0.9× 83 0.8× 102 0.9× 148 1.7× 30 892
Anni Steentoft Denmark 20 546 1.7× 243 1.6× 32 0.3× 96 0.9× 63 0.7× 65 1.0k
Kirsten Wiese Simonsen Denmark 19 520 1.6× 213 1.4× 20 0.2× 124 1.1× 60 0.7× 45 994
Wendy M. Bosker Netherlands 14 466 1.4× 458 2.9× 63 0.6× 54 0.5× 33 0.4× 15 889
Mark Chu Australia 8 534 1.6× 432 2.8× 77 0.7× 40 0.4× 176 2.0× 20 890
Arne Helland Norway 13 113 0.3× 44 0.3× 51 0.5× 64 0.6× 81 0.9× 37 490
Fiona J. Couper United States 19 513 1.6× 187 1.2× 24 0.2× 70 0.6× 12 0.1× 24 918
Eugene W Schwilke United States 18 540 1.6× 666 4.3× 58 0.5× 57 0.5× 21 0.2× 20 980
Thomas Daldrup Germany 19 193 0.6× 391 2.5× 17 0.2× 61 0.6× 29 0.3× 58 1.1k
Anita Holmgren Sweden 26 849 2.6× 366 2.3× 36 0.3× 55 0.5× 69 0.8× 45 1.4k

Countries citing papers authored by B. E. Smink

Since Specialization
Citations

This map shows the geographic impact of B. E. Smink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. E. Smink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. E. Smink more than expected).

Fields of papers citing papers by B. E. Smink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. E. Smink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. E. Smink. The network helps show where B. E. Smink may publish in the future.

Co-authorship network of co-authors of B. E. Smink

This figure shows the co-authorship network connecting the top 25 collaborators of B. E. Smink. A scholar is included among the top collaborators of B. E. Smink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. E. Smink. B. E. Smink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Hondebrink, Laura, Saskia J. Rietjens, Tibor M. Brunt, et al.. (2017). Fatalities, Cerebral Hemorrhage, and Severe Cardiovascular Toxicity After Exposure to the New Psychoactive Substance 4-Fluoroamphetamine: A Prospective Cohort Study. Annals of Emergency Medicine. 71(3). 294–305. 24 indexed citations
2.
Smink, B. E., et al.. (2014). Prevalence of medicinal drugs in suspected impaired drivers and a comparison with the use in the general Dutch population. Forensic Science International. 241. 203–211. 10 indexed citations
3.
Houwing, Sjoerd, B. E. Smink, Sara‐Ann Legrand, et al.. (2012). Repeatability of oral fluid collection methods for THC measurement. Forensic Science International. 223(1-3). 266–272. 11 indexed citations
4.
Smink, B. E., Toine C. G. Egberts, Klaas J. Lusthof, Donald R. A. Uges, & Johan J. de Gier. (2010). The Relationship between Benzodiazepine Use and Traffic Accidents. CNS Drugs. 24(8). 639–653. 140 indexed citations
5.
Pehrsson, Anna, Pirjo Lillsunde, Sjoerd Houwing, et al.. (2010). An analytical evaluation of eight on-site oral fluid drug screening devices using laboratory confirmation results from oral fluid. Forensic Science International. 208(1-3). 173–179. 65 indexed citations
6.
Smink, B. E., Klaas J. Lusthof, J.J. de Gier, Donald R. A. Uges, & Toine C. G. Egberts. (2008). The relation between the blood benzodiazepine concentration and performance in suspected impaired drivers. Journal of Forensic and Legal Medicine. 15(8). 483–488. 16 indexed citations
7.
Smink, B. E., Kris L. L. Movig, Klaas J. Lusthof, et al.. (2008). The Relation Between the Use of Psychoactive Substances and the Severity of the Injury in a Group of Crash-Involved Drivers Admitted to a Regional Trauma Center. Traffic Injury Prevention. 9(2). 105–108. 17 indexed citations
8.
Smink, B. E., et al.. (2008). The concentration of oxazepam and oxazepam glucuronide in oral fluid, blood and serum after controlled administration of 15 and 30 mg oxazepam. British Journal of Clinical Pharmacology. 66(4). 556–560. 31 indexed citations
9.
Verschraagen, Miranda, et al.. (2007). Post-mortem cases involving amphetamine-based drugs in the Netherlands. Forensic Science International. 170(2-3). 163–170. 51 indexed citations
10.
Leufkens, Tim, Annemiek Vermeeren, B. E. Smink, Peter van Ruitenbeek, & Johannes G. Ramaekers. (2007). Cognitive, psychomotor and actual driving performance in healthy volunteers after immediate and extended release formulations of alprazolam 1 mg. Psychopharmacology. 191(4). 951–959. 48 indexed citations
11.
Smink, B. E., Mpm Mathijssen, Klaas J. Lusthof, et al.. (2006). Comparison of Urine and Oral Fluid as Matrices for Screening of Thirty-Three Benzodiazepines and Benzodiazepine-like Substances using Immunoassay and LC-MS(-MS). Journal of Analytical Toxicology. 30(7). 478–485. 33 indexed citations
12.
Smink, B. E.. (2006). Digitalisintoxicatie door interactie met paroxetine. 44(7). 211–211.
13.
Smink, B. E., et al.. (2005). Drug use and the severity of a traffic accident. Accident Analysis & Prevention. 37(3). 427–433. 53 indexed citations
16.
Smink, B. E., et al.. (2001). Driving under the influence of alcohol and/or drugs in the Netherlands 1995–1998 in view of the German and Belgian legislation. Forensic Science International. 120(3). 195–203. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026